Research Paper Volume 15, Issue 20 pp 11152—11161
The novel GLP-1/GIP dual agonist DA3-CH improves rat type 2 diabetes through activating AMPK/ACC signaling pathway
Figure 1. DA3-CH greatly improves T2DM symptoms. (A) The level of fasting blood glucose was measured; (B) The HOMA-IR was analyzed; (C) The food consumption was calculated; (D) The water consumption was calculated; (E) The body weight was recorded. * means p <0.05. n=5 for each group.